INTRODUCTION
Mesenchymal stem cells (MSCs) have been isolated from low-density mononuclear cell populations in human and animal tissues, both adult and embryonic, [1] [2] [3] and have been defined by the following two features: the ability to undergo sustained proliferation in vitro and the potential to give rise to multiple mesenchymal cell lineages including osteocytes, chondrocytes, and adipocytes. 2) The use of MSCs is already a reality in regenerative medicine, 4) a striking example of which is the recent success in correcting osteogenesis imperfecta. 5) However, because of their lack of selective markers, their in vivo characteristics, such as their developmental origin, have remained controversial. 6) The paraxial mesoderm reportedly develops into somites and the cranial mesenchyme, and the somites subsequently develop into limb skeletal muscle. 7) Another group has reported that the paraxial mesoderm contributes to the limb mesenchyme. 8) In addition, the lateral plate mesoderm develops into limb bone and cartilage. The lateral mesoderm mainly develops into internal organs 9) and limb bone and cartilage. 8, 10) The intermediate mesoderm develops into kidney mesenchyme. 11) Recent reports have suggested that the neural crest contributes to MSCs in adult bone marrow (BM). 12, 13) Thus, the origin of limb MSCs has not been fully clarified.
The mesp1 gene, which encodes the basic HLH protein Mesp1, is expressed in the mesodermal cell lineage during early gastrulation (6.5 dpc) in nascent mesodermal cells at the first ingression at the end of the primitive streak. Tracing examinations of Mesp1-expressing cells have shown that the generation of the paraxial mesoderm was related to Mesp1 expression, and that Mesp1-expressing cells contributed to somite generation, heart development and the head mesenchyme field. 14, 15) The aim of this study was to identify prospectively the paraxial mesodermal origin of MSCs in limb bone marrow. Prior to this approach, we found two selective MSC markers, PDGFRα and Sca-1, that could be used to isolate a subpopulation of BM mononuclear cells (BMMNCs) with an approximately 120,000-fold higher CFUFs frequency than unfractionated BM. 13, 16) We called this population PαS cells. In this paper, we prospectively compared isolated MSCs (PαS cells) derived from EGFP + early paraxial mesoderm and those derived not from early paraxial mesoderm (EGFP -) but originating from adult Mesp1 promoter-Cre/Floxed--EGFP mice to determine whether early paraxial mesodermal cells contribute to limb bone MSCs.
Materials and Method

Animals
Transgenic mice expressing Cre recombinase under the control of the Mesp1 promoter (Mesp1-Cre) and P0 promoter (P0Cre) were mated with EGFP reporter mice to obtain Mesp1-Cre/Floxed-EGFP transgenic mice and P0-Cre/Floxed-EGFP transgenic mice. Mesp1-Cre mice were provided by Dr. Yumiko Saga (National Institute of Genetics, Mishima, Japan). Transgenic mice that ubiquitously express EGFP under the control of the CAG promoter were kindly provided by Dr. Jun-ichi Miyazaki (Osaka University, Osaka, Japan) and were bred in our animal facility. Adult wild-type mice were purchased for mating from CLEA Japan. All the experimental procedures were approved by the Ethics Committee of Keio University and were in accordance with the Guide for the Care and Use of Laboratory Animals (US National Institutes of Health).
Preparation of BM cell suspension
Femurs and tibias were dissected and crushed with a pestle from 6 to 8 weeks old mice. The crushed bones were washed several times in HBSS+ (Hanks-balanced salt solution supplemented with 2% FBS, 10 mM HEPES, and 1% penicillin/streptomycin), and the cell suspension was filtered through a cell strainer (Falcon) several times (collagenaseuntreated experiments). For collagenasetreated experiments, bone and BM fragments were incubated for 1 h at 37°C in 0.2% collagenase (Wako)/DMEM (Gibco) containing 10 mM HEPES and 1% P/S. Cell suspensions were collected, and the bone and BM fragments were crushed again. The suspension was filtered with a cell strainer and collected by centrifugation at 280xg for 7 min at 4°C. Both collagenase-treated or collagenaseuntreated BM cells were collected in the Mesp1+ early paraxial mesodermal cells supply initial bone marrow mesenchymal stem cells capable of differentiating into neural crest lineage cells pellet and soaked in 1 mL of water (Sigma) for 5 -10 s to burst the red blood cells, after which 1 mL of 2 × PBS containing 4% FBS was added. The cells were resuspended in HBSS+, and the suspension was filtered through a cell strainer.
Preparation of pantasomatous tissues suspension
We extirpated the kidney, fat, brain, lower limb skeletal muscle, heart, gut, middorsal skin, lung, and liver from 6 to 8 weeks old mice. Each of the tissues were washed several times in HBSS+ (Hanks-balanced salt solution supplemented with 2% FBS, 10 mM HEPES, and 1% penicillin/streptomycin), and crushed with scissors and an 18G needle (NIPRO). For the collagenase-treated experiments, the cell suspensions were incubated for 2 h at 37°C in 0.2% collagenase (Wako) / DMEM (Gibco) containing 10 mM HEPES and 1% P/S. The cell suspensions were then collected. The suspension was filtered with a cell strainer and collected by centrifugation at 280xg for 7 min at 4°C. The collagenase-treated cells were collected in the pellet and soaked in 1 mL of water (Sigma) for 5 -10 s to burst the red blood cells, after which time 1 mL of 2 × PBS containing 4% FBS was added. The cells were then resuspended in HBSS+, and the suspension was filtered through a cell strainer.
FACS analysis and cell sorting
The following fluorophore-conjugated antibodies (PE-Cy7, PE, APC or Biotin) were used for analysis and cell sorting: PE-Cy7 conjugated CD45 (30-F11), TER119 (TER-119), APC-conjugated PDGFRα (APA5), PEconjugated Sca-1 (Ly6A/E), and biotin-conjugated PDGFRα. Biotinylated antibodies were visualized with APC-conjugated streptavidin (Invitrogen). The flow cytometry analysis and sorting were performed using a triple-laser MoFlo (Dako) or JSAN (Bay Bioscience) flow cytometer. PI fluorescence was measured, and a live cell gate was defined that excluded the cells positive for PI. Additional gates were defined as positive for PDGFRα and Sca-1 and negative for CD45 and TER119, depending on the isotype control fluorescence intensity.
Sphere forming cultures
Cells from the BM were seeded at 1 × 10 3 cells/mL 17) in a serum-free sphere-forming medium consisting of DMEM/F-12 (1:1) (Gibco) supplemented with insulin (25 µg/mL), transferrin (100 µg/mL), progesterone (20 nM), sodium selenate (30 nM), putrescine (60 nM) (all from Sigma-Aldrich), recombinant human EGF (20 ng/mL) (Pepro Tech), human FGF-basic (20 ng/mL) (Pepro Tech), and B27 (20 ng/mL). 18) Cells were cultured in an incubator at 37°C, 5% CO2, and half of the medium was changed every 3 -4 days.
Differentiation assay
The MSC differentiation assay was performed as described previously. 2) Spheres were plated on poly-L-ornithine / fibronectin-coated 8-well chamber slides and cultured for 10 days in the following differentiation medium: DMEM/F12 (1:1) supplemented with 10% FBS, without any growth factors.
Immunocytochemistry
Differentiated neural crest lineage cells were fixed with 4% paraformaldehyde/PBS, rinsed with PBS, and pretreated with PBS containing 0.3% Triton X-100 for 5 min at room temperature. After blocking in TNB buffer for 30 min at room temperature, the cells were incubated overnight at 4°C with the following primary antibodies: anti-bIII-tubulin (Sigma), GFAP (Dako), and αSMA (Sigma). After washing with PBS, the cells were incubated for 1 h at room temperature with the secondary antibodies. After washing with PBS, the samples were mounted and observed using a universal fluorescence microscope (Axioskop 2 Plus; Carl Zeiss).
RT-PCR
Total RNA was purified with Trizol (Invitrogen) and treated with a Turbo DNA-free kit (Ambion) to remove genomic DNA contamination. The total RNA was then used for a transcription reaction with random primers (Stratagene), according to the manufacturer's instructions. PCR was performed using ExTaq (Takara, Japan). (A) The PI -CD45 -Ter119 -gated PDGFRβ + and EGFP + ratio was analyzed for bone marrow, heart, lung, and fat cells from Mesp1-cre/Floxed-EGFP mice (left) and P0-cre/Floxed-EGFP mice (right) (mean ± SD, n=3). Black dot = wild-type mouse control. Red dot = transgenic mouse.
(B) RT-PCR analysis of Mesp1 expression in whole bone marrow (BM), fat, heart, lung, and ES cells. All the tissues were obtained from 8-week-old adult wild-type ICR. Fat tissue expressed Mesp1 in adult wild-type ICR. GAPDH was used as the experimental control.
(C) The PI -gated EGFP +/-and CD45, Ter119 +/-ratios were analyzed for Mesp1-cre/Floxed-EGFP mouse bone marrow (mean ± SD, n=5).
Results and Discussion
Distribution of early paraxial mesoderm-derived cells among various organs of adult mice
To elucidate the contribution of early mesodermal cells to mesenchymal cells in various organs of adult mice, we extirpated the bone marrow (BM), kidney, fat, brain, lower limb skeletal muscle, heart, gut, middorsal skin, lung, and liver using Mesp1-Cre/ Flowed-EGFP or P0-Cre/Floxed-EGFP transgenic mice in which we were able to trace the paraxial mesodermal cells or neural crest lineage cells, 13, 19) respectively. We first analyzed the frequency of the EGFP + cells in common mesenchymal lineage marker 12) PDGFRβ-positive cells from mononuclear cells in these tissues using flow cytometry. The bone marrow contained 13.4 ± 6.90% Mesp1 + PDGFR β + cells and 6.7 ± 2.34% P0 + PDGFR β + cells, meaning that the majority of mesenchymal cells in adult bone marrow Mesp1+ early paraxial mesodermal cells supply initial bone marrow mesenchymal stem cells capable of differentiating into neural crest lineage cells
were not derived from the paraxial mesoderm or the neural crest. In contrast, Mesp1 + cells contributed strongly to the heart and lung as expected, since it has been reported that the paraxial mesoderm mainly develops into the head mesenchyme and skeletal muscle. 7) On the other hand, only a few P0 + neural crest-derived cells were present in the heart and lung (Fig. 1A) . Although, fat tissue developed from the mesoderm, 20, 21) a moderate amount of mesenchymal cells in the fat tissue were derived from the neural crest. PT-PCR for Mesp1 expression in whole BM, fat, heart, and lung indicated that Mesp1 expression was observed only in fat tissue (Fig. 1B) ; therefore, the EGFP-positive cells in the BM, heart and lung do not reflect the local Mesp1 expression. Initial Mesp1 + early paraxial mesoderm-derived mesenchymal cells also existed in several other tissues (Supp Fig.  1) . Interestingly, the detected EGFP + cells in the bone marrow were mostly present in the CD45 + Ter119 + fraction, which expresses all haematopoietic cells (Fig. 1C) .The first haematopoietic stem cells (HSCs) appear in the aorta-gonad-mesonephros (AGM) region, 22) and other groups have described haematopoietic precursors derived from lateral mesoderm. 23, 24) Thus, pantosomatous mesenchymes had different origins from each other. This result implies that early paraxial mesoderm-derived MSCs existed in pantasomatous mesenchymal cells.
Supplementary Figure 1: MESP1-EGFP + cells among various tissues of transgenic mice.
The PI-CD45 -Ter119 -gated PDGFRβ + and EGFP + ratio was analyzed for kidney, brain, skeletal muscle, gut, skin, and liver cells from Mesp1-cre/Floxed-EGFP mice (left) and P0-cre/Floxed-EGFP mice (right) (mean ± SD, n=3). Black dot = wild-type mouse control. Red dot = Transgenic mouse. Mesp1+ early paraxial mesodermal cells supply initial bone marrow mesenchymal stem cells capable of differentiating into neural crest lineage cells + and Mesp1 -PαS cells and both adherent cells and spheres cultured for 10 days. The total RNA from whole PαS cells was collected and used as a positive control. Snail, p75, and Sox9 were used as neural crest lineage markers. GAPDH was used as an experimental control.
Initial bone marrow MSCs generated from early paraxial mesoderm
PαS (PDGFRα + Sca-1 + CD45 -TER119 -) cells, representing enriched MSCs, contained both Mesp1-EGFP-positive (2.3 ± 0.04%) and negative cells (Fig. 2A) . We next sorted the Mesp1 + or Mesp1 -PαS cells and performed several assays to verify their potency. Both the Mesp1 + and Mesp1 -PαS cells formed fibroblastic colonies at the same frequency and exhibited exactly the same proliferating speed under the maintenance culture conditions (Fig. 2B) . In addition, both cells differentiated into mesenchymal lineage cells including osteocytes, adipocytes and chondrocytes at the same frequency (Fig. 2C) .
RT-PCR analysis confirmed that the mesenchymal lineage cells derived from Mesp1 + or Mesp1 -PαS cells expressed lineage-specific markers, such as bone and cartilage-related genes including Osteocalcin, Osteopontin, Collagen II, and Collagen X, as well as fat-related genes including PPARγ and Adipsin (Fig. 2D) . From this data, we became convinced that at least part of the MSCs pass through the Mesp1 + early paraxial mesoderm stage during differentiation.
Early paraxial mesoderm-derived MSCs can differentiate into neural crest lineages.
Our group previously reported that non-neural crest-derived MSCs differentiated into neural crest lineage cells in P0-Cre/Floxed-EGFP mice. 13) However, the origins of these cells have not been elucidated. We examined whether early paraxial mesoderm-derived MSCs could differentiate into neural crest lineage cells. Both Mesp1 + and Mesp1 -PαS cells exhibited intermediate sphere-formation at the same frequency (Mesp1 + : 6.25 ± 1.0/1000 cells, Mesp1 -: 6.5 ± 1.0/1000 cells, mean ± SD, n=5) (Fig. 3A) . After digestion, the sphere-forming cells differentiated into neural crest lineage cells. Both Mesp1 + PαS and Mesp1 -PαS cells generated neural crest lineage cells including βIII-tubulin-positive neurons, GFAP-positive glial cells, and αSMA-positive smooth muscle cells (Fig. 3B) . RT-PCR analysis revealed that both Mesp1 + and Mesp1 -PαS cells from either adherent cultures or sphere-forming cultures were positive for Snail, p75, and Sox9 (Fig. 3C) . Consequently, early paraxial mesoderm-derived MSCs had the capacity to differentiate into neural crest lineage cells.
Using Mesp1-Cre/Flowed-EGFP transgenic mice, we demonstrated that mesenchymal cells in most tissues contained Mesp1-EGFP + cells. Therefore, we concluded that pantosomatous mesenchymes partially originate from early paraxial mesoderm. Our data also implied that MSCs in bone marrow, originating from pantosomatous paraxial mesoderm, could differentiate into both mesenchymal and neural crest lineage cells. However, Mesp1-EGFP + MSCs are only a portion of the entire fraction, and the majority of mesenchymal cells are derived from elsewhere. Therefore, the existence of nonparaxial mesodermal origins in limb BM MSCs should be verified using specific reportergene transgenic animals in future studies.
